RA Capital Nexus Fund III, L.P.
Director · Mineralys Therapeutics, Inc.
Every open-market stock purchase RA Capital Nexus Fund III, L.P. has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. Insiders sell for many reasons, but they buy with their own money for one — this page tracks where those buys landed inside insider clusters and how the prices paid compare to where the stock trades now.
Where the buys stand today
- BCAX+60.6% vs price paidBicara Therapeutics Inc.
2 purchases totalling $33.0M at an average of $18.00 per share; the stock last traded at $28.91. See all insider buying in BCAX →
Avg price paid$18.00Latest price$28.91Market cap$1.9B - MLYS+115.7% vs price paidMineralys Therapeutics, Inc.
One purchase totalling $17.5M at an average of $13.50 per share; the stock last traded at $29.12. See all insider buying in MLYS →
Avg price paid$13.50Latest price$29.12Market cap$2.6B
Cluster participation
Buys that landed within days of other insiders buying the same stock — the pattern this site exists to catch.
All reported buys
Get alerted the next time RA Capital Nexus Fund III, L.P. — or any insider — buys
We watch every Form 4 as it hits SEC EDGAR and alert you when insiders cluster into the same stock.
About this data
Figures are parsed from RA Capital Nexus Fund III, L.P.'s Form 4 filings on SEC EDGAR (CIK 1883840) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.